Stocktoria
MetaVia Inc. MTVA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-08-05
MetaVia Inc. statistics & valuation
Market cap$7.4M
P / B1.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -116.6% | -169.7% | -54.7% | -41.7% | -91.0% |
| Return on equity | -243.3% | -347.9% | -74.7% | -64.2% | -104.7% |
| Current ratio | 1.93 | 1.94 | 3.78 | 2.85 | 7.69 |
Source: SEC EDGAR filings · CIK 0001638287 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.